Brief: Jatcorp Working To Provide Infant Formula Labelling Information For FDA Approval Process
03/06/2022 01:06
June 3 (Reuters) - Jatcorp Ltd JAT.AX :
* WORKING WITH AUSTRADE TO PROVIDE INFANT FORMULA LABELLING
INFORMATION FOR FDA APPROVAL PROCESS
* HAS SUFFICIENT CAPACITY FOR IT TO EXPORT ITS PRODUCTS INTO
USA
Source text for Eikon: ID:nASX5nYY85
Further company coverage: JAT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jatcorp
See all newsBrief: Jatcorp Posts Third Quarter Revenue From Operations Of A$8.97 Million
Brief: Jatcorp Logs Qtrly Revenue From Operations A$12.38 Million
Brief: Jatcorp Ltd To Raise A$4.2 Million At A$0.15 Per Share
Brief: Jatcorp CEO Sunny Liang Resigns
Brief: Jatcorp's Revenue From Ongoing Ops Reaches A$11.5 Million In Quarter